Regulation of Glucose Control in People with Type 2 Diabetes: A Review and Consensus.

Jeong Taek Woo; Kyung Soo Park; Dong Won Byun; Kyung Soo KO; Yoon Sok Chung; Doo Man Kim; Tae Sun Park; Bong Soo Cha; In Kyu Lee; Joong Yeol Park; Hyun Shik Son; Moon Kyu Lee; Kwang Won Kim; Ho Young Son

Return

Regulation of Glucose Control in People with Type 2 Diabetes: A Review and Consensus.

Author: Jeong Taek WOO ¹ ; Kyung Soo PARK ; Dong Won BYUN ; Kyung Soo KO ; Yoon Sok CHUNG ; Doo Man KIM ; Tae Sun PARK ; Bong Soo CHA ; In Kyu LEE ; Joong Yeol PARK ; Hyun Shik SON ; Moon Kyu LEE ; Kwang Won KIM ; Ho Young SON
Author Information

1. Discussant and author of manuscript (The opinions of members of the committee on the treatment of diabetes mellitus, Korean Diabetes Association were collected in the manuscript writing.), Chairman of the Committee on the Treatment of Diabetes Mellitus, K
Publication Type:Review
MeSH: Blood Glucose; Cardiovascular Diseases; Consensus; Diabetes Complications; Diabetes Mellitus; Drug Combinations; Gliclazide; Glucose; Humans; Indapamide; Perindopril; Solar System; Veterans
From:Korean Diabetes Journal 2010;34(1):16-20
CountryRepublic of Korea
Language:English
Abstract: A conference was convened by the Korean Diabetes Association and the Korean Endocrine Society on September 7, 2009 to discuss and organize the results of research on intensive glucose control for the prevention of cardiovascular disease in patients with type 2 diabetes. Professor Kyung Soo Park led the conference, and Professors Kwang Won Kim and Ho Young Son acted as chairmen. Professors Doo Man Kim, Tae Sun Park, and Bong Soo Cha reported on intensive glucose control and diabetic complications, including the UK Prospective Diabetes Study (UKPDS), Diabetes Control and Complication Trial (DCCT) research results, the recently published Action to Control Cardiovascular Risk in Diabetes (ACCORD), Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE), and Veterans Affairs Diabetes Trial (VADT) research, as well as meta-analyses. Professor Jeong-Taek Woo reported on the manuscript written by the committee for the Korean Diabetes Association which dealt with the treatment of diabetes mellitus. Professors Kyung Soo Ko, Joong Yeol Park, Hyun Shik Son, Moon-Kyu Lee, Dong-Won Byun, and Yoon-Sok Chung participated in the discussion and collected information for the manuscript from all of the participants. The aim of the debate was to determine how to establish target goals for intensive glucose control and how to individualize those goals. The participants concluded that there was no need to modify the recommendation of maintaining an HbA1c under 6.5%, the current blood glucose treatment goal that is recommended by the Korean Diabetes Association. In addition, individual target goals for glucose control were recommended depending on the situation of each patient. We report on the consensus statement from the meeting.